Patents by Inventor Phillip Thomas Hawkins

Phillip Thomas Hawkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7820803
    Abstract: The invention relates to immobilized phosphatidic acid probes which can be used to identify important proteins for signal transduction, housekeeping and diagnosis.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: October 26, 2010
    Inventors: Len Stephens, Phillip Thomas Hawkins, Andrew Bruce Holmes, Maria Manifava, Ze-Yi Lim, Nicholas Ktistakis, Johannes Wilhelmus John Fitzgerald Thuring
  • Publication number: 20040072244
    Abstract: Probes comprising an immobilised Phosphatidic Acid attached onto a solid support are described, for example, as shown in formula I and V: (a) the linker consists of aryl, heteroaryl, alkyl with possible heteroatoms and/or unsaturations, preferably chains of (CH2)n, with n=8-20, most preferably n=11; (b) the heteroatom X maybe O, S, or most preferably NH; (c) the functional group (FG) is a carbonyl from a carboxylate (thiolo)ester, or, most preferably an amide; (d) the R-substituent carries an aryl, alkyl group, or a combination, preferably R=CmH2m+1, m=8-20, m=16 optimal; (e) the ion M represents any cation, preferably Na+, NH4+; (f) unsaturations are allowed, such as in an arachidonyl side chain and (g) =solid support with attachment to functional group, where: R=aryl, alkyl group, or a combination, preferably R=CmH2m+1, m=8-20, m=16 is optimal.
    Type: Application
    Filed: August 28, 2003
    Publication date: April 15, 2004
    Inventors: Len Stephens, Phillip Thomas Hawkins, Andrew Bruce Holmes, Maria Manifava, Ze-Yi Lim, Nicholas Ktistakis, Johannes Wilhelmus John Fitzgerald Thuring
  • Patent number: 6017763
    Abstract: The present invention relates to the discovery, identification and characterization of nucleotides that encode the G protein regulated phosphatidylinositol-3' kinase, a heterodimeric enzyme which produces the intracellular messenger phosphatidylinositol (3,4,5)-triphosphate in response to activation of trimeric G protein-linked receptors. This novel protein, comprised of a catalytic subunit, p120, and a regulatory subunit, p101, is found in cells of hematopoietic origin and is involved in immune system responses which cause inflammation. The presence of p101 subunit is largely responsible for the dramatic stimulation of kinase activity in the presence of activated trimeric G proteins.
    Type: Grant
    Filed: January 4, 1999
    Date of Patent: January 25, 2000
    Assignees: Onyx Pharmaceuticals, Inc., The Babraham Institute
    Inventors: Len Stephens, Phillip Thomas Hawkins, Sylvia Braselmann
  • Patent number: 5869271
    Abstract: The present invention relates to the discovery, identification and characterization of nucleotides that encode the G protein regulated phosphatidylinositol-3' kinase, a heterodimeric enzyme which produces the intracellular messenger phosphatidylinositol (3,4,5)-triphosphate in response to activation of trimeric G protein-linked receptors. This novel protein, comprised of a catalytic subunit, p120, and a regulatory subunit, p101, is found in cells of hematopoietic origin and is involved in immune system responses which cause inflammation. The presence of p101 subunit is largely responsible for the dramatic stimulation of kinase activity in the presence of activated trimeric G proteins.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: February 9, 1999
    Assignee: Onyx Pharmaceuticals
    Inventors: Len Stephens, Phillip Thomas Hawkins
  • Patent number: 5859201
    Abstract: The present invention relates to the discovery, identification and characterization of nucleotides that encode the G protein regulated phosphatidylinositol-3' kinase, a heterodimeric enzyme which produces the intracellular messenger phosphatidylinositol (3,4,5)-triphosphate in response to activation of trimeric G protein-linked receptors. This novel protein, comprised of a catalytic subunit, p120, and a regulatory subunit, p101, is found in cells of hematopoietic origin and is involved in immune system responses which cause inflammation. The presence of p101 subunit is largely responsible for the dramatic stimulation of kinase activity in the presence of activated trimeric G proteins.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: January 12, 1999
    Assignee: Onyx Pharmaceuticals
    Inventors: Len Stephens, Phillip Thomas Hawkins
  • Patent number: 5856132
    Abstract: The present invention relates to the discovery, identification and characterization of nucleotides that encode the G protein regulated phosphatidylinositol-3' kinase, a heterodimeric enzyme which produces the intracellular messenger phosphatidylinositol (3,4,5)-triphosphate in response to activation of trimeric G protein-linked receptors. This novel protein, comprised of a catalytic subunit, p120, and a regulatory subunit, p101, is found in cells of hematopoietic origin and is involved in immune system responses which cause inflammation. The presence of p101 subunit is largely responsible for the dramatic stimulation of kinase activity in the presence of activated trimeric G proteins.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: January 5, 1999
    Assignee: Onyx Pharmaceuticals
    Inventors: Len Stephens, Phillip Thomas Hawkins, Sylvia Braselmann
  • Patent number: 5856133
    Abstract: The present invention relates to the discovery, identification and characterization of nucleotides that encode the G protein regulated phosphatidylinositol-3'kinase, a heterodimeric enzyme which produces the intracellular messenger phosphatidylinositol (3,4,5)-triphosphate in response to activation of trimeric G protein-linked receptors. This novel protein, comprised of a catalytic subunit, p120, and a regulatory subunit, p101, is found in cells of hematopoietic origin and is involved in immune system responses which cause inflammation. The presence of p101 subunit is largely responsible for the dramatic stimulation of kinase activity in the presence of activated trimeric G proteins.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: January 5, 1999
    Assignee: Onyx Pharmaceuticals
    Inventors: Len Stephens, Phillip Thomas Hawkins